Talaris Therapeutics, Inc. (TALS) Social Stream
TALARIS THERAPEUTICS INC (TALS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering TALARIS THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-01 | 4 | $35 | $21 | $29.25 | $2.7 | 983.33% |
| 2022-01-28 | 4 | $35 | $22 | $29.5 | $2.7 | 992.59% |
| 2022-03-17 | 4 | $35 | $20 | $25.75 | $2.7 | 853.7% |
| 2022-03-22 | 4 | $35 | $21 | $26 | $2.7 | 862.96% |
| 2022-05-12 | 4 | $35 | $21 | $25.75 | $2.7 | 853.7% |
| 2022-05-24 | 4 | $35 | $20 | $25.5 | $2.7 | 844.44% |
| 2022-08-24 | 2 | $8 | $7 | $7.5 | $2.7 | 177.78% |
| 2022-09-09 | 2 | $7 | $6 | $6.5 | $2.7 | 140.74% |
| 2022-10-24 | 3 | $18 | $2 | $8.666 | $2.7 | 220.96% |
| 2023-02-16 | 3 | $12 | $2 | $6.666 | $2.7 | 146.89% |
| 2023-03-31 | 3 | $12 | $2 | $5.666 | $2.7 | 109.85% |
| 2023-05-16 | 3 | $3 | $2 | $2.5 | $2.7 | -7.41% |
| 2023-06-26 | 2 | $3 | $3 | $3 | $2.7 | 11.11% |
| NA | 1 | $NA | $NA | $NA | $2.7 | NA% |
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
TALS's average price target has moved down $22.75 over the prior 14 months.
Over the past 35 weeks, TALS's average upside potential has been 222.32%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-24 | 3 | 12 | 2 | 6.666 | 1.49 | 347.38% |
| 2023-02-23 | 3 | 3 | 3 | 3.000 | 1.93 | 55.44% |
| 2023-02-23 | 2 | 3 | 3 | 3.000 | 1.93 | 55.44% |
| 2023-02-23 | 3 | 12 | 2 | 5.666 | 1.93 | 193.58% |
| 2023-05-16 | 3 | 3 | 2 | 2.500 | 2.53 | -1.19% |
TALS Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 3 | 0 | 0 | 2 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
TALS's average broker recommendation rating worsened by 1.75 over the prior 15 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, TALARIS THERAPEUTICS INC's number of analysts covering the stock is higher than 149.76% of them.
- To contextualize these metrics, consider that out of all US stocks, TALARIS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1279.68% of them.
- TALARIS THERAPEUTICS INC's average analyst price target is higher than 292.51% of all US stocks.
- In the context of Pharmaceutical Products stocks, TALARIS THERAPEUTICS INC's variance in analysts' estimates is lower than -449.75% of them.
In the Pharmaceutical Products industry, MOLN, IPSC, and AMAM are the three stocks most similar to TALARIS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is TALS a Buy, Hold or Sell? See the POWR Ratings now!